Two tumor subtypes, with distinct TIME and patient prognosis, were identified by scRNA-seq of 14 iCCA specimens based on the differential expression of the markers S100P and SPP1 (osteopontin) [24]. The gene discussed is SPP1; the disease is neoplasm.